THE APEX TIMES
L3Harris Insider Sales Keep Making Headlines as Executives Report Share Disposals in SEC Filings
Recent Form 4 disclosures, including sales by CEO Christopher Kubasik and other insiders, underscore how liquidity-driven selling can coexist with prearranged trading plans in the defense contractor’s executive ranks.
L3Harris Technologies has come under renewed scrutiny after a Yahoo Finance market column flagged an apparent pattern of insider selling over the past year, a development that can catch investors’ attention even when it is not unusual in highly compensated executive circles. The company’s share transactions are documented through SEC filings that report when executives or directors buy and sell stock, including transactions tied to equity awards and prearranged trading plans.
One example appears in an SEC Form 4 filed in June 2025 for CEO Christopher E. Kubasik. That filing shows sales reported on June 11 and June 12, 2025. The Form 4 lists a sale of 2,212 shares on June 11, 2025 and a sale of 33,061 shares on June 12, 2025. The filing also includes a remark that the transactions reflect weighted average sale prices, with the earlier sale reported at an average price in the mid-$247 range and the later sale at an average price in the upper-$248 range. The presence of large, scheduled sales by a top executive is often what drives the type of concerns raised in commentary like the Yahoo Finance piece.
Other insider transactions in 2026 include sales reported by directors and senior officers. An SEC Form 4 covering transactions with a reporting person identified as Jon Rambeau (a company officer) lists a sale transaction code of “S” for 5,528 shares dated March 2, 2026, with a reported price of $370.32 per share. Separately, another Form 4 for Samir Mehta shows a similar “S” sale line item for 5,528 shares dated March 2, 2026, also with a reported price of $370.32 per share. While these filings do not offer commentary on motives, they provide concrete timestamps and share counts that help quantify selling activity.
L3Harris’s filings also show that at least some executive stock sales are conducted through Rule 10b5-1 plans. In a disclosure dated February 4, 2026, the company said Kubasik established a written prearranged plan under Rule 10b5-1 during an open trading window. The disclosure states the plan removes discretion from the executive over timing of sales, and it covers sales scheduled to begin in May 2026 and run through October 30, 2026, subject to minimum price thresholds.
According to that February 2026 disclosure, the 10b5-1 plan covers sales of vested options to purchase up to 129,501 shares granted in 2019, plus 60,000 shares of common stock. Rule 10b5-1 is a provision that allows certain sales to be executed under predetermined conditions; it is designed to help address concerns that executives might trade based on material nonpublic information. The key point for readers is that prearranged plans can create a steady stream of reported insider selling that may not reflect new, real-time bearish information about the business.
In defense contracting, executive compensation often includes equity awards that vest over multiple years. When those awards mature or when executives need diversification or liquidity, selling reported in Form 4 filings can rise even without any negative change in fundamentals. The defense sector’s long program cycles and backlog dynamics can also mean that equity holdings and scheduled selling are handled on a plan basis rather than case-by-case decision making.
What remains unclear is how much of the overall selling highlighted in external commentary is directly tied to predetermined plans versus sales connected to equity vesting mechanics, tax-related withholding, or other personal financial needs. SEC Form 4 documents also typically do not explain intent, and the public disclosures for a given quarter rarely consolidate the “why” behind each sale into a single narrative.
Looking ahead, L3Harris investors will likely focus on follow-on SEC reports that reflect the execution of prearranged 10b5-1 schedules and any additional Form 4 activity from other insiders. Over the remainder of 2026, the company’s disclosures could show whether the selling cadence continues at a pace consistent with preplanned activity or whether it accelerates in ways that would merit additional questions.
Why It Matters
- Insider selling does not automatically indicate deteriorating fundamentals, especially when sales occur under Rule 10b5-1 schedules and vesting-related transactions.
- Large sales by executives can still influence market perception because they are visible in SEC filings and can coincide with periods of heightened debate about defense contractor valuations.
- The timing window for the disclosed 10b5-1 plan (May through October 2026) sets an expectation for continued Form 4 activity, which may affect how investors interpret subsequent insider transactions.
Sources
- story (Yahoo Finance)
- L3Harris Investor Relations (company IR landing page)
- L3Harris disclosure of CEO 10b5-1 plan (Feb. 4, 2026) PDF
- SEC Form 4 (Kubasik) showing 2025 sales on June 11 and June 12, 2025
- SEC Form 4 (Rambeau) showing a 2026 sale line item dated March 2, 2026
- SEC Form 4 (Mehta) showing a 2026 sale line item dated March 2, 2026
- L3Harris 10b5-1 explanation in SEC filing
- Image
Key Facts
- A Yahoo Finance column raised concerns about insider selling at L3Harris over the past year.
- SEC Form 4 filings show CEO Christopher Kubasik reported share sales on June 11 and June 12, 2025, including 2,212 shares and 33,061 shares respectively.
- The Kubasik Form 4 includes a remark that the sales reflect weighted average sale prices.
- SEC Form 4 activity in 2026 includes sales reported at $370.32 per share for 5,528 shares dated March 2, 2026, in filings for insiders including Jon Rambeau and Samir Mehta.
- On February 4, 2026, L3Harris disclosed that Kubasik established a Rule 10b5-1 plan with predetermined sales dates starting in May 2026 through October 30, 2026, subject to minimum price thresholds.
- The disclosed 10b5-1 plan covers sales of vested options up to 129,501 shares and 60,000 shares of common stock.
Defense Related
Northrop Grumman and RTX lift full-year earnings outlook, citing record backlog
Northrop Grumman said it is raising its full-year adjusted earnings outlook, echoing similar guidance changes from RTX, as defense contractors point to demand strength reflected in a record backlog.
Northrop Grumman’s Q3 earnings call highlighted growth and backlog, while sidestepping several specifics
In remarks carried by market media on its third-quarter earnings call, Northrop Grumman said it saw sales growth across all four business segments, pointed to a record backlog, and raised its outlook, framing demand around strategic deterrence. Investors seeking more granular detail on timing and contract mix were left without answers in the cited discussion.
RTX reports Q3 2026 adjusted sales of $25 billion, citing growth across commercial and defense businesses
The defense and aerospace contractor told investors that third-quarter adjusted sales rose to $25 billion, with company executives pointing to strength spanning commercial equipment, commercial aftermarket and defense operations.
RTX CEO: Missile-contract backlog could provide nearly a decade of demand visibility after Q3 results
On a post-earnings call, RTX’s leadership pointed to missile-related contracts as a potential stabilizer for production planning, while describing steps to expand capacity and reduce supply bottlenecks.
Boeing announces retirement of commercial sales chief Brad McMullen, with Ryan Weir set to take over North America sales
The leadership change comes as the planemaker continues to manage fallout related to its 2024 mid-air incident and related commercial activity.
RTX faces 2027 Pentagon sourcing rules aimed at rare-earth magnets
A new Pentagon policy beginning in January 2027 would require rare-earth magnets used in U.S. defense systems to be free of Chinese-origin materials, creating a new compliance and supplier challenge for RTX and its magnet-dependent subcontractors.
RTX Q3 earnings review highlights how key metrics measured up against Wall Street expectations
A market-focused note tied to RTX’s latest quarterly results examined the company’s reported revenue and earnings per share, then framed several performance indicators against consensus forecasts for the quarter ended September 2026.
RTX’s cash rebound draws attention to receivables sales, not just business momentum
A closer look at RTX’s cash flow improvement suggests that faster collections through receivable sales helped lift operating cash in the first half, alongside firmer demand tied to aircraft maintenance and defense.